We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Johnson & Johnson’s device revenues dropped by more than 11 percent in the most recent quarter, the New Brunswick, N.J.-based health care giant reported Tuesday. Read More